一个强大的计算任务:发现潜在的成功结果,以改善耐皮拉津胺结核菌耐药性结核菌的治疗
Muhammad Shahab1, Gabriel Christian de Farias Morais2, Shopnil Akash3
1State key laboratories of Chemical Resources Engineering Beijing, University of Chemical Technology, Beijing, China.
Journal of cellular and molecular medicine
|April 18, 2024
概括
耐皮拉津胺结核病 (TB) 是一个日益增长的威胁. 这项研究使用了计算方法来了解耐药机制,并确定治疗耐药Mycobacterium结核病 (MTB) 的新药候选者.
科学领域:
- 生物化学和分子生物学
- 计算化学计算化学
- 药物发现 药物发现 药物发现
背景情况:
- 耐皮拉津胺 (PZA) 的Mycobacterium结核病菌 (MTB) 菌株对结核病 (TB) 治疗具有重大挑战.
- 抗PZA耐药性通常与RpsA蛋白的突变有关,特别是G97D突变,影响其与酸的相互作用.
- 了解结构动态和抵抗机制对于开发新的治疗策略至关重要.
研究的目的:
- 阐明在MTB中PZA耐药性的基础分子机制.
- 为了确定新型的化合物,有效地对抗抗 PZA 耐药的 MTB 菌株.
- 为了利用计算方法快速和经济有效的候选药物发现.
主要方法:
- 整合多尺度生物分子和分子动力学模拟.
- 物理化学和药物化学预测的应用.
- 使用量子计算和化学数据库的虚拟选 (ZINC和Chembridge).
主要成果:
- 阐明与RpsA突变相关的抵抗机制.
- 确定了五种潜在的化合物 (ZINC15913786,ZINC20735155,Chem10269711,Chem10279789,Chem10295790) 用于抗PZA的MTB.
- 演示计算方法作为传统药物查的可行替代方案.
结论:
- 计算方法为药物结合部位和抗PZA耐药MTB的疗效提供了准确的见解.
- 已识别的化合物需要进一步的体外和体内验证.
- 这项研究强调了计算分析在加速开发新的结核病药物的重要性.
关键词:
结核病菌菌菌的结核病菌的结核病菌.接收人 接收人停靠的对接方式分子动力学分子动力学分子建模分子建模药品信息系统是药品信息系统.基于药的虚拟查.皮拉津胺的耐药性 皮拉津胺耐药性量子化学计算的量子化学计算更多相关视频
09:57Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
Published on: December 14, 2016
10.5K
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
7.8K
相关概念视频
Pulmonary Tuberculosis V
179
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
179
Pulmonary Tuberculosis IV
142
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
142
Pulmonary Tuberculosis II
228
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
228
